Abstract
We recently demonstrated that daily whole egg consumption during moderate carbohydrate restriction leads to greater increases in plasma HDL-cholesterol (HDL-C) and improvements in HDL profiles in metabolic syndrome (MetS) when compared to intake of a yolk-free egg substitute. We further investigated the effects of this intervention on HDL composition and function, hypothesizing that the phospholipid species present in egg yolk modulate HDL lipid composition to increase the cholesterol-accepting capacity of subject serum. Men and women classified with MetS were randomly assigned to consume either three whole eggs (EGG, n = 20) per day or the equivalent amount of egg substitute (SUB, n = 17) throughout a 12-week moderate carbohydrate-restricted (25–30 % of energy) diet. Relative to other HDL lipids, HDL-cholesteryl ester content increased in all subjects, with greater increases in the SUB group. Further, HDL-triacylglycerol content was reduced in EGG group subjects with normal baseline plasma HDL-C, resulting in increases in HDL-CE/TAG ratios in both groups. Phospholipid analysis by mass spectrometry revealed that HDL became enriched in phosphatidylethanolamine in the EGG group, and that EGG group HDL better reflected sphingomyelin species present in the whole egg product at week 12 compared to baseline. Further, macrophage cholesterol efflux to EGG subject serum increased from baseline to week 12, whereas no changes were observed in the SUB group. Together, these findings suggest that daily egg consumption promotes favorable shifts in HDL lipid composition and function beyond increasing plasma HDL-C in MetS.
Similar content being viewed by others
Abbreviations
- ABCA1:
-
ATP-binding cassette transporter A1
- ABCG1:
-
ATP-binding cassette transporter G1
- BCA:
-
Bicinchoninic acid
- CAD:
-
Coronary artery disease
- CE:
-
Cholesteryl ester
- CerPCho:
-
Sphingomyelin
- CETP:
-
Cholesteryl ester transfer protein
- CVD:
-
Cardiovascular disease
- DMPC:
-
Dimyristoylphosphatidylcholine
- EGG:
-
Whole egg group
- FC:
-
Free cholesterol
- HDL-C:
-
Plasma HDL-cholesterol
- HDL-PL:
-
HDL-phospholipids
- LCAT:
-
Lecithin-cholesterol acyltransferase
- LysoPtdCho:
-
Lysophosphatidylcholine
- NCEP ATP III:
-
National Cholesterol Education Program Adult Treatment Panel III
- MetS:
-
Metabolic syndrome
- PL:
-
Phospholipid
- PtdCho:
-
Phosphatidylcholine
- PtdEtn:
-
Phosphatidylethanolamine
- PtdIns:
-
Phosphatidylinositol
- RCT:
-
Reverse cholesterol transport
- SDS:
-
Sodium dodecyl sulfate
- SR-BI:
-
Scavenger receptor class B I
- SUB:
-
Egg yolk-free egg substitute group
- TAG:
-
Triacylglycerol
References
Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH (2008) The metabolic syndrome. Endocr Rev 29:777–822
Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH (2009) The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 50(Suppl):S189–S194
Asztalos BF, Tani M, Schaefer EJ (2011) Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol 22:176–185
Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res 95:764–772
Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127–135
Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342–374
Tchoua U, Gillard BK, Pownall HJ (2010) HDL superphospholipidation enhances key steps in reverse cholesterol transport. Atherosclerosis 209:430–435
Fournier N, Paul JL, Atger V, Cogny A, Soni T, de la Llera-Moya M, Rothblat G, Moatti N (1997) HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 17:2685–2691
Rosenson RS, Brewer HB Jr, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ (2011) HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem 57:392–410
Dashti M, Kulik W, Hoek F, Veerman EC, Peppelenbosch MP, Rezaee F (2011) A phospholipidomic analysis of all defined human plasma lipoproteins. Sci Rep 1:139
Zhang W, Asztalos B, Roheim PS, Wong L (1998) Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I. J Lipid Res 39:1601–1607
Piperi C, Kalofoutis C, Papaevaggeliou D, Papapanagiotou A, Lekakis J, Kalofoutis A (2004) The significance of serum HDL phospholipid levels in angiographically defined coronary artery disease. Clin Biochem 37:377–381
Bovet P, Darioli R, Essinger A, Golay A, Sigwart U, Kappenberger L (1989) Phospholipids and other lipids in angiographically assessed coronary artery disease. Atherosclerosis 80:41–47
Fournier N, de la Llera Moya M, Burkey BF, Swaney JB, Paterniti J Jr, Moatti N, Atger V, Rothblat GH (1996) Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res 37:1704–1711
Mweva S, Paul JL, Cambillau M, Goudouneche D, Beaune P, Simon A, Fournier N (2006) Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity. Eur J Clin Invest 36:552–559
Klimov AN, Konstantinov VO, Lipovetsky BM, Kuznetsov AS, Lozovsky VT, Trufanov VF, Plavinsky SL, Gundermann KJ, Schumacher R (1995) “Essential” phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. Cardiovasc Drugs Ther 9:779–784
Bunea R, El Farrah K, Deutsch L (2004) Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 9:420–428
Mutungi G, Ratliff J, Puglisi M, Torres-Gonzalez M, Vaishnav U, Leite JO, Quann E, Volek JS, Fernandez ML (2008) Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. J Nutr 138:272–276
Iwata T, Hoshi S, Takehisa F, Tsutsumi K, Furukawa Y, Kimura S (1992) The effect of dietary safflower phospholipid and soybean phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet. J Nutr Sci Vitaminol (Tokyo) 38:471–479
Wat E, Tandy S, Kapera E, Kamili A, Chung RW, Brown A, Rowney M, Cohn JS (2009) Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 205:144–150
Kullenberg D, Taylor LA, Schneider M, Massing U (2012) Health effects of dietary phospholipids. Lipids Health Dis 11:3
Zierenberg O, Grundy SM (1982) Intestinal absorption of polyenephosphatidylcholine in man. J Lipid Res 23:1136–1142
Weihrauch JL, Son Y-S (1983) The phospholipid content of foods. J Am Oil Chem Soc 60:1971–1978
Cohn JS, Kamili A, Wat E, Chung RW, Tandy S (2010) Dietary phospholipids and intestinal cholesterol absorption. Nutrients 2:116–127
Mutungi G, Waters D, Ratliff J, Puglisi M, Clark RM, Volek JS, Fernandez ML (2010) Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem 21:261–267
Blesso CN, Andersen CJ, Barona J, Volek JS, Fernandez ML (2013) Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome. Metabolism 62:400–410
Blesso CN, Andersen CJ, Bolling BW, Fernandez ML (2013) Egg intake improves carotenoid status by increasing plasma HDL cholesterol in adults with metabolic syndrome. Food Funct 31:213–221
Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89:4963–4971
(2001) Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13–e18
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ (2012) Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J Lipid Res 53:1890–1909
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917
Mayurasakorn K, Srisura W, Sitphahul P, Hongto PO (2008) High-density lipoprotein cholesterol changes after continuous egg consumption in healthy adults. J Med Assoc Thai 91:400–407
Klein BE, Klein R, Lee KE (2002) Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25:1790–1794
Hong Y, Jin X, Mo J, Lin HM, Duan Y, Pu M, Wolbrette DL, Liao D (2007) Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all—cause mortality-results of prospective analysis for the atherosclerosis risk in communities study. J Intern Med 262:113–122
Shuhei N, Soderlund S, Jauhiainen M, Taskinen MR (2010) Effect of HDL composition and particle size on the resistance of HDL to the oxidation. Lipids Health Dis 9:104
Park KH, Shin DG, Kim JR, Hong JH, Cho KH (2010) The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Int J Mol Med 25:129–136
Parra ES, Urban A, Panzoldo NB, Nakamura RT, Oliveira R, de Faria EC (2011) A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women. Lipids Health Dis 10:87
Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, Lewis GF (1999) Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 103:1191–1199
Skeggs JW, Morton RE (2002) LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J Lipid Res 43:1264–1274
Kinoshita M, Fujita M, Usui S, Maeda Y, Kudo M, Hirota D, Suda T, Taki M, Okazaki M, Teramoto T (2004) Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL. Atherosclerosis 173:197–202
Arsenault BJ, Lemieux I, Despres JP, Gagnon P, Wareham NJ, Stroes ES, Kastelein JJ, Khaw KT, Boekholdt SM (2009) HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis 206:276–281
Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, Kraemer WJ, Bibus DM, Fernandez ML, Feinman RD (2009) Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 44:297–309
Smirnov MD, Esmon CT (1994) Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 269:816–819
Griffin JH, Kojima K, Banka CL, Curtiss LK, Fernandez JA (1999) High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 103:219–227
Bradamante S, Barenghi L, Giudici GA, Vergani C (1992) Free radicals promote modifications in plasma high-density lipoprotein: nuclear magnetic resonance analysis. Free Radic Biol Med 12:193–203
Navab M, Hama S, Hough G, Fogelman AM (2003) Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation 108:1735–1739
Wang H, Du J, Lu S, Yao Y, Hunter F, Black DD (2001) Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine. Lipids 36:683–687
Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F, Hayden MR (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 116:1052–1062
Rachmilewitz D, Fainaru M (1979) Apolipoprotein A-I synthesis and secretion by cultured human intestinal mucosa. Metabolism 28:739–743
Xu M, Zhou H, Gu Q, Li C (2009) The expression of ATP-binding cassette transporters in hypertensive patients. Hypertens Res 32:455–461
Xu M, Zhou H, Wang J, Li C, Yu Y (2009) The expression of ATP-binding cassette transporter A1 in Chinese overweight and obese patients. Int J Obes (Lond) 33:851–856
Nakanishi S, Vikstedt R, Soderlund S, Lee-Rueckert M, Hiukka A, Ehnholm C, Muilu M, Metso J, Naukkarinen J, Palotie L, Kovanen PT, Jauhiainen M, Taskinen MR (2009) Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity. J Lipid Res 50:183–192
Gantman A, Fuhrman B, Aviram M, Hayek T (2010) High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx. Biochem Biophys Res Commun 391:523–528
Wang X, Liao D, Bharadwaj U, Li M, Yao Q, Chen C (2008) C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 28:519–526
Ervin RB (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report:1–7
Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A (2008) Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. Eur J Endocrinol 158:53–60
Alenezi MY, Marcil M, Blank D, Sherman M, Genest J Jr (2004) Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect? J Clin Endocrinol Metab 89:761–764
Duong M, Collins HL, Jin W, Zanotti I, Favari E, Rothblat GH (2006) Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 26:541–547
Jian B, de la Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH (1998) Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 273:5599–5606
Aron-Wisnewsky J, Julia Z, Poitou C, Bouillot JL, Basdevant A, Chapman MJ, Clement K, Guerin M (2011) Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab 96:1151–1159
Acknowledgments
This study was supported in part by the Egg Nutrition Center from funds received by MLF, and by the Agriculture and Food Research Initiative Competitive Grant No. 2012-67011-19914 from the USDA National Institute of Food and Agriculture to CJA. Mass spectrometric analyses were performed in the Mass Spectrometer Facility of CCCWF School of Medicine and supported in part by NCI Center Grant 5P30CA12197. The Finnigan TSQ Quantum XLS GC/MS/MS was purchased with funds from NIH Shared Instrumentation Grant 1S10RR027940MS to MJT.
Conflict of Interest
MLF received funds from the Egg Nutrition Center to perform the study. CJA, CNB, JL, JB, DS, and MJT declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Andersen, C.J., Blesso, C.N., Lee, J. et al. Egg Consumption Modulates HDL Lipid Composition and Increases the Cholesterol-Accepting Capacity of Serum in Metabolic Syndrome. Lipids 48, 557–567 (2013). https://doi.org/10.1007/s11745-013-3780-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-013-3780-8